Weight Loss Drugs Are Maxing Out Daddy’s Credit Card

Most insurance plans, including Medicare and Medicaid, do not cover drugs for weight loss. Why should you?

Why should you indemnify anyone +$10,000 a year for a weight loss drug they don’t need when they can exercise, control their diet and lead a healthy lifestyle instead?

For those plan sponsors covering weight loss drugs it’s time to take away Daddy’s credit card. Stop enriching PBMs (yes, they get a commission on every prescription disguised as a ‘rebate’) and put in a sensible weight loss program instead. It’s called individual responsibility.

State Employee Health Plan Ends Weight Loss Drug Coverage

University of Texas Dropping Weight Loss Drug Coverage

Heuro Health’s Obesity & Diabetes Management Program Can Make A Difference

Type 2 Diabetes Remission Program For The Lower Rio Grande ValleyObesity is a leading factor among diabetics. It takes a dedicated journey to achieve lasting weight loss which is hard to do unless you have a program in place that’s proven to work.

JEFF BERHARD, PRESIDENT OF HUERO HEALTH:

The obesity epidemic in the United States has escalated type 2 diabetes to unprecedented levels. It’s surprising that the majority of resources are allocated to treating type 2 diabetes rather than addressing its primary cause in about 85% of cases—excess weight.

Previously considered a secondary option, GLP/GIP medications are now the primary treatment for type 2 diabetes. These drugs are covered by 97% of self-funded Plan Sponsors with just a simple prior authorization to confirm the diagnosis.

Heuro Health is currently engaging with self-funded employers who find that 50% of their type 2 diabetic employees/dependents are on these costly medications, significantly impacting their healthcare budgets. This trend is financially unsustainable and is only increasing. According to the ADA, this number will rise to 60% of all type-2 diabetics will be on GLP/GIP medications by 2026. This requires a strategy and plan to mitigate these increases through diabetes remission.

Merely using GLP/GIP agonists is very unlikely to bring type 2 diabetes into remission. A successful approach involves a 24-month, comprehensive program guided by obesity specialists, RD’s, neuroplasticity coaches and effective tools used by patients daily.

Heuro Health stands out as a leading national care provider, helping to reduce GLP/GIP costs for employers. Our program supports weight loss and overall metabolic health and has achieved a 60% remission rate in our two-year journey. Participants in our program significantly reduce their dependency on expensive diabetic medications, regain their health sustainably, and decrease employer healthcare costs by 75%.

Our members appreciate our white-glove approach to care and service. We eliminate barriers to care, bringing solutions directly to our clients, and meeting them wherever they are.

If you are a broker, consultant, or employer looking to enhance your employees’ health and significantly reduce GLP/GIP expenses, contact me to explore our effective solutions.

Type 2 Diabetes Remission is possible

The U.S. Marine Corp 6 week weight loss program never fails…………….